Literature DB >> 11905992

The alpha7 nicotinic receptors in human fetal brain and spinal cord.

Lena Falk1, Agneta Nordberg, Ake Seiger, Anders Kjaeldgaard, Ewa Hellström-Lindahl.   

Abstract

The alpha7 nicotinic acetylcholine receptor subtype is believed to be involved in the regulation of neuronal growth, differentiation and synapse formation during the development of the human brain. In this study the expression of the alpha7 nicotinic acetylcholine receptor was investigated in human fetal brain and spinal cord of 5-11 weeks gestational age. Both the specific binding of [125I]alpha-bungarotoxin to prenatal brain membranes and the expression of alpha7 mRNA were significantly higher in the pons, medulla oblongata, mesencephalon and spinal cord of 9-11 weeks gestational age compared with cerebellum, cortex and subcortical forebrain. A significant positive correlation between gestational age and the expression of alpha7 mRNA was observed in all brain regions except cortex. A positive correlation was also observed between the gestational age and the [125I]alpha-bungarotoxin binding in the pons, medulla oblongata, mesencephalon, and cerebellum. Consequently, a significant relationship between the alpha7 mRNA levels and the binding sites for [125I]alpha-bungarotoxin was found in the fetal brain. The increasing levels of the alpha7 nicotinic acetylcholine receptor during the first trimester support the important role of nAChRs for the development of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11905992     DOI: 10.1046/j.0022-3042.2001.00714.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Early exposure to nicotine during critical periods of brain development: Mechanisms and consequences.

Authors:  Andrew M Smith; Linda P Dwoskin; James R Pauly
Journal:  J Pediatr Biochem       Date:  2010

2.  Evidence for Alpha7 Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough.

Authors:  Brendan J Canning; Qi Liu; Mayuko Tao; Robert DeVita; Michael Perelman; Douglas W Hay; Peter V Dicpinigaitis; Jing Liang
Journal:  J Pharmacol Exp Ther       Date:  2021-11-15       Impact factor: 4.402

3.  Exposure to elevated embryonic kynurenine in rats: Sex-dependent learning and memory impairments in adult offspring.

Authors:  Silas A Buck; Annalisa M Baratta; Ana Pocivavsek
Journal:  Neurobiol Learn Mem       Date:  2020-07-30       Impact factor: 2.877

4.  Comparative developmental neurotoxicity of organophosphates in vivo: transcriptional responses of pathways for brain cell development, cell signaling, cytotoxicity and neurotransmitter systems.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2007-01-25       Impact factor: 4.077

Review 5.  The dynamic effects of nicotine on the developing brain.

Authors:  Jennifer B Dwyer; Susan C McQuown; Frances M Leslie
Journal:  Pharmacol Ther       Date:  2009-03-05       Impact factor: 12.310

6.  Is fetal brain monoamine oxidase inhibition the missing link between maternal smoking and conduct disorders?

Authors:  Ruben D Baler; Nora D Volkow; Joanna S Fowler; Helene Benveniste
Journal:  J Psychiatry Neurosci       Date:  2008-05       Impact factor: 6.186

7.  Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats.

Authors:  Ana Pocivavsek; Marian A R Thomas; Greg I Elmer; John P Bruno; Robert Schwarcz
Journal:  Psychopharmacology (Berl)       Date:  2014-03-04       Impact factor: 4.530

8.  Developmental hippocampal neuroplasticity in a model of nicotine replacement therapy during pregnancy and breastfeeding.

Authors:  Ian Mahar; Rosemary C Bagot; Maria Antonietta Davoli; Sharon Miksys; Rachel F Tyndale; Claire-Dominique Walker; Marissa Maheu; Sheng-Hai Huang; Tak Pan Wong; Naguib Mechawar
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

9.  Central cholinergic signal-mediated neuroendocrine regulation of vasopressin and oxytocin in ovine fetuses.

Authors:  Lijun Shi; Caiping Mao; Fanxing Zeng; Yuying Zhang; Zhice Xu
Journal:  BMC Dev Biol       Date:  2008-10-02       Impact factor: 1.978

10.  Neurotrophic factors promote cholinergic differentiation in human embryonic stem cell-derived neurons.

Authors:  Mats Nilbratt; Omar Porras; Amelia Marutle; Outi Hovatta; Agneta Nordberg
Journal:  J Cell Mol Med       Date:  2009-10-03       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.